Sponsor

OSIVAX Belgique

Belgium Rue Des Chasseurs-Ardennais 7, 4031 Liege, Belgium

About the sponsor

OSIVAX Belgique’s clinical research activity is centered on influenza prevention, with interest in vaccine-based protection for healthy adults. The sponsor’s work focuses on immune response and protection following administration of an influenza vaccine candidate.

Influenza immunisation
Vaccine-induced immunity
Seasonal respiratory infection prevention

Its research landscape reflects a targeted focus on adult vaccination and the evaluation of protective immune responses in the context of influenza control.

About Specializations

OSIVAX Belgique runs clinical trials in conditions such as Influenza, among others.

Influenza

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Influenza

Not recruiting

InvestigationalNo placebo

A Study of OVX836 Influenza Vaccine Given as Booster or Primary Vaccination in Healthy Adults Who Previously Received OVX836, Influenza Vaccine, or Placebo

InvestigationalNo placebo

Belgium

Participants:18–64 years · Healthy volunteers
Substances:INFLUENZA A (H1N1/WSN/1933) NUCLEOPROTEIN FUSED TO C-TERMINAL FRAGMENTS OF TWO AVIAN C4BP ALFA CHAIN SEQUENCES
Sponsor:OSIVAX Belgique

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →